Categories: Automobile

Ampace Unveils Breakthroughs in E-Motorcycles and Battery Swap Solutions at EICMA

MILAN, Nov. 6, 2025 /PRNewswire/ — Ampace, a globally leading lithium battery manufacturer, showcased its latest innovations at EICMA in Milan. The company introduced advanced e-motorcycle technologies and new battery swap solutions, aimed at enhancing both performance and business models.

- Advertisement -

E-Motorcycle Innovations: E30P and Kun-Era Series

- Advertisement -

Ampace’s e-motorcycle solutions are built around its self-developed BP system, which strikes a balance between energy density, stability, and power. Two key products took the spotlight:

- Advertisement -

E30P Cell: Designed for e-motorcycles, this cylindrical cell supports fast charging—reaching 95% in 47 minutes and 50% in just 15 minutes. It powers the industry’s first 72V90Ah large-capacity battery pack, delivering a range of up to 195 km. The cell maintains over 90% capacity after 2,000 cycles and shows minimal degradation even after 250 days at 45°C. Thanks to Ampace’s proprietary technology, it also achieves over 100% capacity retention throughout the first 300 cycles.

- Advertisement -

Kun-Era Series: Featuring six core advantages, including safety, power, and lightweight design, this series supports continuous discharge of 120A, enabling acceleration from 0–50 km/h in under 3 seconds. A full charge to 80% takes roughly 40 minutes, and dual battery packs provide over 150 km of range. Models like the Wuyang-Honda’s E-VO GT and NIU’s NX Hyper already use this technology, with the E-VO GT achieving a top speed of 120 km/h and setting a lap record at the Zhuhai International Circuit.

- Advertisement -

Battery Swap Solutions: Efficiency and Reliability

- Advertisement -

For delivery and e-moto taxi riders, battery range and power are crucial. Instead of slow charging, battery swap services get them back on the road faster. Ampace powers this system with high-performance, reliable batteries. Their high-capacity, long-life units are tested over 200 times for durability. Enabling “one swap per day” and featuring high-precision BMS with 80A or 100A output, Ampace batteries turn efficiency directly into income.

- Advertisement -

Commitment to Ultimate Quality and Safety

- Advertisement -

Ampace’s products are supported by intelligent manufacturing and rigorous safety standards. The company uses a high-speed coating process and over 5,000 quality control points to ensure consistency. Batteries are tested with more than 16,000 test cases to validate performance under extreme conditions.

- Advertisement -

Ampace continues to invest in R&D and collaborate with partners to build a safer, more reliable mobility ecosystem. As stated by Ms. Lin Xiaojing, President of Ampace’s Micro E-mobility Business Department: ” We are committed to delivering a promise of ‘Safe Arrival’ for two-wheeler users worldwide.”

- Advertisement -

Photo – https://mma.prnewswire.com/media/2815492/a7a1e05367ba889c45a56aab630bdb5f.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/ampace-unveils-breakthroughs-in-e-motorcycles-and-battery-swap-solutions-at-eicma-302606854.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

20 hours ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago